A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2009
12/17/2009	WO2009152480A2 Methods to treat solid tumors
12/17/2009	WO2009152462A2 Method of regulating cell growth using a proteasome inhibitor
12/17/2009	WO2009152245A1 Treatment of cancers of the blood using selected glycomimetic compounds
12/17/2009	WO2009152228A2 Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen
12/17/2009	WO2009152210A2 Coumarin compounds and their use for treating cancer
12/17/2009	WO2009152167A2 Delivery of therapeutics
12/17/2009	WO2009152087A1 Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
12/17/2009	WO2009152083A1 5h-pyrr0l0 [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
12/17/2009	WO2009152082A1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors
12/17/2009	WO2009151920A2 Hepsin inhibitors
12/17/2009	WO2009151910A2 Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
12/17/2009	WO2009151762A2 Anticancer methods using extracts of anemarrhena asphodeloides bunge
12/17/2009	WO2009151742A2 Methods for identifying nuclear receptor/ligand combinations for targeting brain tumor stem cells for their use
12/17/2009	WO2009151644A2 Small molecule inhibitors of autotaxin methods of use
12/17/2009	WO2009151599A1 Substituted pyrroles and methods of use
12/17/2009	WO2009151598A1 Diazacarbazoles and methods of use
12/17/2009	WO2009151589A1 Diazacarbazoles and methods of use
12/17/2009	WO2009151569A2 Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders
12/17/2009	WO2009151456A1 Thiazole compounds, and compositions and methods using same
12/17/2009	WO2009151069A1 Imidazothiazole derivative having 4,7-diazaspiro[2.5]octane ring structure
12/17/2009	WO2009150888A1 Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent
12/17/2009	WO2009150835A1 Iqgap3 epitope peptides and vaccines containing the same
12/17/2009	WO2009150470A2 Suppression of cancers
12/17/2009	WO2009150469A2 Suppression of neuroendocrine diseases
12/17/2009	WO2009150462A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
12/17/2009	WO2009150448A1 Improvements in platinum compounds preparation by use of tetrabutylammounium amminetrichloroplatinate as intermediate
12/17/2009	WO2009150405A1 Combination of spacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine
12/17/2009	WO2009150388A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
12/17/2009	WO2009150387A1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
12/17/2009	WO2009150381A2 Azacarboline derivatives, preparation method thereof and therapeutic use of same
12/17/2009	WO2009150240A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
12/17/2009	WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009	WO2009150129A1 Heterocyclic derivatives as hdac inhibitors
12/17/2009	WO2009149837A1 Substituted 4- (indazolyl) -1,4-dihydropyridines and methods of use thereof
12/17/2009	WO2009149836A1 Annellated 4- (indazolyl) -1,4-dihydropyridine derivatives and methods of use thereof
12/17/2009	WO2009149599A1 Liposome medicament and preparation method and use thereof
12/17/2009	WO2009149496A1 Treatment of diabetes and complications thereof and related disorders
12/17/2009	WO2009131486A3 Photosensitiser and a method for the production thereof
12/17/2009	WO2009130296A3 Anti-alk1 antibodies and uses thereof
12/17/2009	WO2009129401A8 Kinase inhibitors
12/17/2009	WO2009129208A8 Compositions and methods of inducing endoplasmic reticulum stress reponse
12/17/2009	WO2009126651A3 Mat ii subunit rnai and therapeutic methods using same
12/17/2009	WO2009126315A3 Macrocyclic compounds and methods of treatment
12/17/2009	WO2009126274A3 Methods and compositions for the treatment of cancers, such as melanomas and gliomas
12/17/2009	WO2009120922A3 Compositions and methods for inhibiting pdgfrbeta and vegf-a
12/17/2009	WO2009119980A3 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
12/17/2009	WO2009117669A3 Treatment with opioid antagonists and mtor inhibitors
12/17/2009	WO2009109867A3 Crystal form of phenylamino pyrimidine derivative
12/17/2009	WO2009108762A3 Methods and compositions for treatment of retinoid-responsive conditions
12/17/2009	WO2009106361A3 Inhibitors of cell proliferation and uses thereof
12/17/2009	WO2009100690A8 Amourphous form of the adamantylamino-platinum ( iv) complexla-12
12/17/2009	WO2009091374A3 Fused heterocyclic derivatives and methods of use as c-met inhibitors
12/17/2009	WO2009085209A3 Methods for using and identifying modulators of delta-like 4
12/17/2009	WO2009074827A3 Combination comprising a mek inhibitor and an aurora kinase inhibitor
12/17/2009	WO2009062740A9 Use of an ozone/oxygen mixture as primary anticancer therapy through intraperitoneal insufflation
12/17/2009	WO2009058907A3 Targeting micrornas for the treatment of liver cancer
12/17/2009	WO2009053644A8 Use of lanthanide-based nanoparticles as radiosensitizing agents
12/17/2009	WO2009046834A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections
12/17/2009	WO2009043481A3 Use of adrenomedullin 13-52 and optionally retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009043439A3 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009043437A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections
12/17/2009	WO2009040072A3 Use of angiotensin i as a therapeutic agent in the treatment of eg aids or tuberculosis
12/17/2009	WO2009040071A3 Use of cyclo-rgdfv and optionally angiotensin i as therapeutic agents in the treatment of eg aids or tuberculosis
12/17/2009	WO2009040029A3 Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis
12/17/2009	WO2009040028A3 Use of casoxin c and optionally adrenomedullin as therapeutic agents for the treatment of excessive angiogenesis
12/17/2009	WO2009039968A3 Use of angiotensin iii as a therapeutic agent in the treatment of eg hbv infection
12/17/2009	WO2009039966A3 Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection
12/17/2009	WO2009039957A3 Use of angiotensin ii as a therapeutic agent in the treatment of eg s. pneumoniae infection
12/17/2009	WO2009033796A8 Use of a peptide as a therapeutic agent
12/17/2009	WO2009033707A3 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009033661A3 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
12/17/2009	WO2009027644A3 Compositions for the treatment of neoplastic diseases
12/17/2009	WO2008144931A8 Compositions and methods for modulating gated ion channels
12/17/2009	WO2008129308A3 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss
12/17/2009	WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/17/2009	US20090312554 Novel Process for the Preparation of Hexacyclic Compounds
12/17/2009	US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009	US20090312430 Colchicine solid-state forms; methods of making; and methods of use thereof
12/17/2009	US20090312417 Platinum(ii) complexes, preparation and use
12/17/2009	US20090312407 Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of Cancer and other Pathologies
12/17/2009	US20090312405 Methods to Predict and Prevent Resistance to Taxoid Compounds
12/17/2009	US20090312396 Methods for cancer treatment using tak1 inhibitors
12/17/2009	US20090312393 Cancer therapy using bcl-xl-specific sina
12/17/2009	US20090312391 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases
12/17/2009	US20090312379 Dimeric Small Molecule Potentiators of Apoptosis
12/17/2009	US20090312374 Derivatives of 4,6-disubstituted 1,2,4-triazolo- 1,3,4-thiadiazole, a process and uses thereof
12/17/2009	US20090312373 Methods for the treatment of cancer using piperlongumine and piperlongumine analogs
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009	US20090312360 Antineoplastic Combinations Containing HKI-272 and Vinorelbine
12/17/2009	US20090312353 Methods and compositions for treating liquid tumors
12/17/2009	US20090312349 Anti-inflammatory medicaments
12/17/2009	US20090312343 Quinazoline derivatives as tyrosine kinase inhibitors
12/17/2009	US20090312336 Dihydropteridine compounds as anti proliferative agents
12/17/2009	US20090312324 Compositions and Methods Related to RAD51 Inactivation in the Treatment of Neoplastic Diseases, and Especially CML
12/17/2009	US20090312320 Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereof
12/17/2009	US20090312319 Certain chemical entities, compositions and methods
12/17/2009	US20090312316 Novel compounds
12/17/2009	US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same
12/17/2009	US20090312310 Imidazothiazole derivatives
12/17/2009	US20090312308 Compounds and compositions as hedgehog signaling pathway modulators

1 ... 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 ... 2211